The secretion of glucocorticoid hormones is tightly regulated by the circadian clock and by negative humoral feedback loops, both acting on the hypothalamic-pituitary gland-adrenal axis. However, a new study (Ishida et al., 2005 [this issue of Cell Metabolism]) shows that light can influence the adrenal's glucocorticoid output by a more direct pathway.
Main Text
It has been known for a long time that plasma glucocorticoid hormone levels follow robust daily oscillations, which are driven by the master circadian clock in the suprachiasmatic nucleus (SCN) via the hypothalamicpituitary gland-adrenal axis. As a consequence, the transcription of many glucocorticoid-responsive genes in peripheral organs may fluctuate during the day. However, glucocorticoids may also act on the circadian expression of genes that are not directly glucocorticoid sensitive, namely by acting as timing cues for cellautonomous clocks in peripheral tissues. The paper by Ishida et al. (2005) suggests that this synchronization could be accomplished by a novel pathway in which light directly stimulates adrenal glucocorticoid synthesis and secretion via the SCN and the splanchic nerve.
Glucocorticoids-cortisone in humans and corticosterone in rodents-participate in a dazzling array of physiological functions. During starvation, they increase glucose supply for the brain and other tissues by promoting hepatic gluconeogenesis and by stimulating the breakdown of lipids and proteins to metabolites that can serve as substrates for gluconeogenesis. They act as immunosupressors by stimulating Tlymphocyte apoptosis, and as anti-inflammatory agents by interfering with proinflammatory cytokine secretion. Furthermore, they play important roles in lung surfactant production, bone homeostasis, mammary gland development, and memory consolidation (Miller and Tyrell, 1995) . More recently, glucocorticoid signaling has also been shown to participate in the timing of circadian rhythms in peripheral cell types and organs (Le Minh et al., 2001) . Mice homozygous for a glucocorticoid null allele die shortly after birth due to respiratory failure (Cole et al., 1995) .
Glucocorticoids are produced from cholesterol in the adrenal cortex. Due to their lipophilic nature, they can directly diffuse into cells, where they activate the glucocorticoid receptor by releasing it from inactive, cytosolic complexes with chaperones and immunophilins. The ligand bound receptor migrates to the nucleus, binds to glucocorticoid-responsive elements (GREs) within promoter or enhancer regions, and, depending on the protein-protein interactions it establishes with other transcription factors such as cJun, cFos, NFkB, STATs, and SMADs, can enhance or repress transcription of target genes (Schoneveld et al., 2004) .
Given the critical functions glucocorticoids have in many physiological processes, the plasma levels of these hormones are tightly regulated. Classically, this control was believed to be exerted exclusively by the central nervous system on the hypothalamic-pituitary-adrenal (HPA) axis and by negative humoral feedback loops within this axis. Thus, inputs from various brain regions, including the suprachiasmatic nucleus harboring the central circadian timekeeper, elicit secretion of corticotropin-releasing factor (CRF) from specialized neurons in the hypothalamus. CRF then stimulates the secretion of adrenocorticotropic hormone (ACTH) from corticotroph cells in the pituitary gland, which in turn triggers the synthesis and secretion of glucocorticoid hormones in the adrenal cortex. Due to the influence of the circadian clock on CRF secretion, glucocorticoid levels oscillate with robust daily rhythms in the plasma of most mammals, reaching peak levels just before the onset of the activity period. In addition, glucocorticoids repress their own synthesis through two negative feedback loops, by inhibiting the synthesis of CRF in hypothalamic neurons and ACTH in pituitary gland corticotrophs (Tronche et al., 1998) .
Recent evidence, however, has suggested that in response to dehydration, the sympathetic nervous system can stimulate glucocorticoid secretion in the adrenal gland of rats directly via splanchnic nerve innervation. Such regulation might be of wide physiological significance since glucocorticoid synthesis has been documented in the absence of elevated ACTH levels in a wide variety of cases-anorexia, depression, Alzheimer's disease, ischemic injury, and abdominal or brain injury (Ulrich-Lai and Engeland, 2002, and references therein). abdominal organs. When examining anesthetized mPer1-luc mice exposed to light, the authors found that mPer1 expression was strongly induced in the adrenal gland shortly after the light treatment. Subsequent microarray analysis showed that this surge of mPer1 expression was accompanied by the expression of other immediate early genes, such as CREM (cAMP responsive element modulator) and members of the Nr4a and Nr5a nuclear receptor subfamilies. More importantly, light potently induced the production of corticosterone in the adrenal cortex and elicited a rise of corticosterone concentrations in both the blood plasma and the cerebrospinal fluid. Lesion experiments indicated that both the SCN and the adrenal nerve are required for light-induced corticosterone secretion. However, as light had no influence on ACTH plasma levels, the stimulation of adrenal cortex activity by light does not appear to involve the HPA axis.
The physiological significance of this new pathway, which is schematically outlined alongside the more classical one in Figure 1 , is still open to speculations. Conceivably, the light-induced increase in corticosterone secretion could participate in the phase resetting of circadian oscillators throughout the body. Consistent with this hypothesis, the glucocorticoid receptor is present in all peripheral tissues and in most brain regions. Interestingly, however, it is absent from the suprachiasmatic nucleus itself, perhaps preventing the master clock from being influenced by its own commands (Balsalobre et al., 2000) . In peripheral organs and fibroblasts grown in tissue culture, mPer1 expression and subsequent phase shifts in circadian gene expression are induced by a large variety of chemical signals, including the glucocorticoid receptor agonist dexamethasone (Balsalobre et al., 2000) . Moreover, Cushing's syndrome patients, who experience a wide range of physiological problems due to constitutively elevated cortisone levels, also suffer from sleep-related circadian abnormalities (Friess et al., 1995) . If a light-induced pathway were also operative in humans, a question that could readily be examined by recording plasma cortisone levels after light exposure, it would be tempting to speculate that cortisonemediated synchronization of peripheral circadian clocks would be one of the beneficial effects light therapy has on patients affected by seasonal affective disorder (SAD). It might also explain why bright light therapy can aid patients with other depressive disorders not typically associated with the circadian clock (e.g., major depressive disorder and bipolar disorder) (Kripke, 1998) . In short, from the perspectives of both chronobiologists and clinicians, sympathetic signaling to the adrenal gland could prove to be of great physiological interest. 
